Explore our ready-to-market cosmetic prototypes engineered with biocompatible actives, superior skin affinity, and flexible ingredient customization.
Targeting the root pathophysiology of fungal acne (*Malassezia folliculitis*), seborrheic dermatitis, and impaired stratum corneum integrity through intelligent biochemical synthesis.
Traditional creams use triglycerides and fatty acids with carbon chains between C11 and C24, which directly nourish fungal proliferation. Our ODM bio-reactors formulate using pure synthetic squalane, Caprylic/Capric Triglycerides, and mineral humectants to inhibit fungal food sources while locking in hydration.
We synthesize synergized complexes combining micro-encapsulated Climbazole, Piroctone Olamine, Zinc Pyrithione (ZPT), and natural Terpinen-4-ol. This multi-target mechanism disrupts fungal ergosterol synthesis and cell membrane permeability without triggering topical antibiotic resistance.
Fungal overgrowth triggers cutaneous immune responses, resulting in relentless pruritus, scaling, and erythematous flares. Our formulations integrate bio-identical Ceramides NP/AP/EOP, Madecassoside, and Ectoine to instantly calm hyper-reactive epidermal tissue and restore moisture barrier defense.
The convergence of clinical dermatology and prestige cosmetics has transformed the global antifungal face care segment from a niche pharmacy staple into an estimated $18.4 billion global opportunity by 2030.
Demand in the United States and Canada is moving rapidly from clinical pharmaceutical creams toward non-prescription, daily-use dermo-cosmetics. Consumers are actively seeking "Malassezia Safe" labeling, gentle exfoliating acid hybrids, and lightweight gel-cream delivery formats suited for oily and acne-prone skin.
Under EU Regulation (EC) No 1223/2009, European consumers demand rigorously substantiated cosmetic claims that avoid harsh pharmaceutical preservatives. Our green biotech formulas preserve the cutaneous microbiome while effectively controlling yeast proliferation on reactive skin.
High humidity and seasonal heat in Southeast Asia, Southern China, and Japan drive extreme demand for sweat-resistant, non-comedogenic antifungal formulas. Consumers require sebum-absorbing, ultra-breathable emulsions that mitigate follicular pustules exacerbated by protective face masks.
Guangzhou Beaza Biotechnology Co., Ltd. operates two state-of-the-art facilities—Guangzhou Aoyan Cosmetics Co., Ltd. and Guangzhou Xinzimei Cosmetics Co., Ltd.—providing comprehensive documentation to clear international customs and retail hurdles without delay.
We deliver complete analytical dossiers for every production batch, including ISO 22716 certification, Good Manufacturing Practices (GMPC), Certificate of Analysis (COA), Safety Data Sheets (MSDS), and strict Heavy Metal / Preservative Challenge Test reports.
Facilitating seamless international distribution through complete Cosmetic Product Safety Reports (CPSR), full Product Information Files (PIF), EU CPNP notifications, and strict compliance with FDA Voluntary Cosmetic Registration Program (VCRP) and MoCRA protocols.
Full support for Saudi Food & Drug Authority (SFDA/SASO) conformity certificates, Certificates of Free Sale (CFS), and Certificates of Origin (CO). Our regulatory team customizes product ingredient declarations (INCI) to comply with localized labeling mandates.
Our adaptable contract manufacturing and ODM pipelines are tailored to fit diverse brand positionings, customer price points, and functional skincare niches.
Engineered for clinical dispensing following micro-needling, laser peeling, or chemical abrasion where opportunistic fungal breakouts frequently appear. Provides intensive epidermal comfort without clogging traumatized pores.
Created for digitally native skincare brands addressing the surging search volume around "Fungal Acne" and "Seborrheic Itch." Formulated with trendy textures—cloud water creams, soufflé gels, and velvety matte primers.
High-friction facial zones and sweat accumulation in athletic environments trigger fungal flares along the hairline, jaw, and T-zone. Formulated with breathable bio-polymers that preserve active protection through intense workouts.
Targeted solutions for tinea barbae and folliculitis in coarse beard zones. Formulated as a fast-penetrating fluid emulsion that treats underlying skin without coating facial hair in greasy white residues.
Leveraging our "1+2+2+N+N" collaborative laboratory model, Beaza unites university researchers, raw-material suppliers, and production chemists to develop next-generation bio-fermented skincare solutions.
By trapping sensitive antimicrobial molecules inside sub-micron lipid spheres, our SLN delivery system achieves sustained epidermal release over 18 hours. This enhances bio-availability while significantly decreasing skin contact irritation.
Moving beyond conventional broad antimicrobials, our research pipeline is deploying engineered bioactive peptides that target the cell walls of Malassezia globosa and Candida albicans without harming protective commensal bacteria.
Our labs use predictive algorithmic simulations to analyze dynamic emulsion stability across extreme thermal ranges (-10°C to +50°C). This ensures zero phase separation, lipid oxidation, or active degradation across international freight routes.
A streamlined, fully traceable manufacturing model designed to compress your product launch window from twelve months down to six weeks.
Brand positioning, target skin conditions, pricing goals, and target-market regulatory screening.
Lab sample generation, scent and texture evaluation, and container compatibility checks.
Artwork approval, airless pump/tube validation, INCI compliance, and stability dossier preparation.
Cleanroom bulk emulsification, automated packaging, batch coding, and strict in-process QC inspection.
Issuance of per-batch COAs, export documentation, customs clearance, and global ocean/air delivery.
Complete your brand regimen with companion cleansers, treatment toners, balancing lotions, and specialized dermo-care products.
Expert answers covering contract manufacturing, Malassezia-safe formulation, regulatory dossiers, and packaging compatibility.